CINECA IRIS Institutional Research Information System

MONTRUCCHIO, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.744
EU - Europa 3.461
AS - Asia 1.602
SA - Sud America 34
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 9.881
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.653
CN - Cina 889
IT - Italia 726
DK - Danimarca 437
IE - Irlanda 405
SE - Svezia 354
SG - Singapore 353
UA - Ucraina 318
DE - Germania 293
FR - Francia 269
FI - Finlandia 231
KR - Corea 175
GB - Regno Unito 139
PL - Polonia 92
AT - Austria 69
CA - Canada 62
VN - Vietnam 60
BE - Belgio 22
ID - Indonesia 22
RU - Federazione Russa 20
IN - India 19
MX - Messico 19
CH - Svizzera 17
ES - Italia 17
JP - Giappone 17
PT - Portogallo 16
BR - Brasile 15
SN - Senegal 14
NL - Olanda 13
HK - Hong Kong 12
TH - Thailandia 12
CO - Colombia 10
PH - Filippine 10
TW - Taiwan 8
AU - Australia 7
UZ - Uzbekistan 7
RO - Romania 6
EU - Europa 5
TR - Turchia 5
HT - Haiti 4
SA - Arabia Saudita 4
A1 - Anonimo 3
CU - Cuba 3
NG - Nigeria 3
NO - Norvegia 3
PE - Perù 3
UY - Uruguay 3
AR - Argentina 2
BG - Bulgaria 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DM - Dominica 2
HR - Croazia 2
IL - Israele 2
LU - Lussemburgo 2
MY - Malesia 2
TG - Togo 2
BD - Bangladesh 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
KE - Kenya 1
KZ - Kazakistan 1
MT - Malta 1
MU - Mauritius 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
SC - Seychelles 1
ZA - Sudafrica 1
Totale 9.881
Salva come PNG Salva come JPEG
Città #
Ann Arbor 676
Beijing 622
Chandler 533
Dublin 402
Santa Clara 395
Singapore 289
Jacksonville 234
Villeurbanne 184
Torino 182
Dearborn 181
Ashburn 165
Wilmington 150
Princeton 143
Houston 135
Fairfield 134
Medford 118
Nyköping 117
Columbus 106
Warsaw 92
Woodbridge 70
Milan 67
Vienna 66
Seattle 58
Boston 56
New York 51
Cambridge 45
Dong Ket 44
Fremont 44
Turin 42
Guangzhou 37
Pisa 37
Hefei 32
Boardman 31
Munich 31
Redwood City 27
Toronto 25
San Mateo 24
Helsinki 23
Shanghai 23
Verona 23
Washington 23
Brussels 19
Jakarta 18
Nanjing 17
Falls Church 14
Norwalk 14
Buffalo 12
Chicago 12
Detroit 12
Kunming 12
Hangzhou 10
Montréal 10
Ottawa 10
Palaiseau 10
San Diego 10
Stockholm 10
Grafing 9
Nanchang 9
Lachine 8
Rome 8
Teresina 8
Alessandria 7
Florence 7
Hong Kong 7
Mountain View 7
Perugia 7
Trieste 7
Wuhan 7
Jinan 6
Mexico City 6
Upper Marlboro 6
Xian 6
Zhengzhou 6
Bologna 5
Chengdu 5
Düsseldorf 5
Hebei 5
Kaifeng 5
Modena 5
Palermo 5
Pavia 5
Shenyang 5
Taipei 5
Tokyo 5
Auburn Hills 4
Baotou 4
Barcelona 4
Bari 4
Central District 4
Fiorano Modenese 4
Fuzhou 4
Lappeenranta 4
London 4
Los Angeles 4
Madrid 4
Monterrey 4
Nürnberg 4
Padova 4
Phoenix 4
Port-au-Prince 4
Totale 6.167
Salva come PNG Salva come JPEG
Nome #
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 429
Bleeding prevalence and transfusion requirement in patients with thrombocytopenia in the emergency department 309
Joint use of cardio-embolic and bleeding risk scorers in elderly patients with atrial fibrillation. 305
THE STORM (acute coronary Syndrome in paTients end Of life and Risk assesMent) study Claudio Moretti 241
Phosphoinositide 3-kinase gamma controls autonomic regulation of the mouse heart through Gi-independent downregulation of cAMP level 240
Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing 229
Phosphoinositide 3-kinase gamma-deficient hearts are protected from the PAF-dependent depression of cardiac contractility. 229
Ablation of phosphoinositide 3-kinase-gamma reduces the severity of acute pancreatitis 222
Resistance to thromboembolism in PI3-K gamma-deficient mice 208
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 198
Phosphoinositide 3-kinase gamma: kinase-dependent and -independent activities in cardiovascular function and disease 196
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 180
Role of phosphoinositide 3-kinase in the pathogenesis of acute pancreatitis. 176
Increased levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria 164
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 156
Pancreatic-carcinoma-cell-derived pro-angiogenic factors can induce endothelial-cell differentiation of a subset of circulating CD34+ progenitors. 148
Platelets and multi-organ failure in sepsis 133
Effect of cytokines on the cytoskeleton of resident glomerular cells. 132
Blockade of thrombopoietin reduces organ damage in experimental endotoxemia and polymicrobial sepsis 130
AISF position paper on HCV in immunocompromised patients 126
Thymic stromal lymphopoietin in human pancreatic ductal adenocarcinoma: Expression and prognostic significance 124
Elevated thrombopoietin in plasma of burned patientswithout and with sepsis enhances platelet activation 122
[Physiopathological mechanisms in the natural history of the atherosclerotic plaque] 118
May thrombopoietin be a useful marker of sepsis severity assessment in patients with SIRS entering the emergency department? 116
Thrombopoietin as early biomarker of disease severity in patients with acute pancreatitis 116
Plasma Lactate Dehydrogenase Levels Predict Mortality in Acute Aortic Syndromes 116
Thrombopoietin modulates cardiac contractility in vitro and contributes to myocardial depressing activity of septic shock serum 113
Thrombopoietin contributes to enhanced platelet activation in cigarette smokers 108
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study. 102
Cooperative role of thrombopoietin and vascular endothelial growth factor-a in the progression of liver cirrhosis to hepatocellular carcinoma 94
Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. 90
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia. 89
Detection of platelet-activating factor in gingival tissue surrounding failed dental implants. 87
Effect of platelet activating factor on guinea pig papillary muscle. 86
Angiogenesis induced in vivo by hepatocyte growth factor is mediated by platelet-activating factor synthesis from macrophages. 85
Thrombopoietin (TPO) Contributes to Platelet Activation in Human Diseases 84
Alterazioni immunologiche in corso di uremia cronica. 84
THROMBOPOIETIN MAY CONTRIBUTE TO VENTILATOR-INDUCED LUNG INJURY 84
Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist. 83
Platelet-activating factor-induced endothelial cell expression of adhesion molecules and modulation of surface glycocalyx, evaluated by electron spectroscopy chemical analysis. 83
Effect of leukocyte stimulation on rabbit immune complex glomerulonephritis. 82
Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. 80
Thrombopoietin contributes to enhanced platelet activation in patients with type 1 diabetes mellitus 80
Derivation and validation of a biomarker-based clinical algorithm to rule out sepsis from noninfectious systemic inflammatory response syndrome at emergency department admission: A multicenter prospective study 79
Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. 78
Determination of 1-O-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine, platelet-activating factor and related phospholipids in biological samples by high-performance liquid chromatography--tandem mass spectrometry. J Chromatogr B Biomed Appl. 78
The role of platelet-activating factor in experimental immune complex pathology 77
Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. 77
The pattern of cardiovascular alterations induced by infusion of platelet-activating factor in rabbit is modified by pretreatment with H1-H2 receptor antagonists but not by cyclooxygenase inhibition. 77
Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. 77
In vitro contractile effect of platelet-activating factor on guinea-pig myometrium. 74
Effect of platelet-activating factor (PAF) on human cardiac muscle. 72
Involvement of thrombopoietin in the development of organ injury in a mouse model of cecal ligation and puncture-induced sepsis 71
Release of platelet-activating factor in systemic lupus erythematosus. 70
IN VITRO OXYTOCIC ACTIVITY OF PLATELET-ACTIVATING FACTOR OH HUMAN MYOMETRIUM 70
Platelet-activating factor-mediated contraction of rabbit lung strips: pharmacologic modulation. 70
The membrane attack complex of complement contributes to plasmin-induced synthesis of platelet-activating factor by endothelial cells and neutrophils. 70
Detection of platelet-activating factor in plasma of patients with streptococcal nephritis. 68
Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. 68
Streptokinase induces intravascular release of platelet-activating factor in patients with acute myocardial infarction and stimulates its synthesis by cultured human endothelial cells. 66
Immunopathology and progression of experimental renal disease. 66
Isolated radiation-induced mitral stenosis: a yet undescribed valvulopathy 66
Platelet-activating factor (PAF) induces platelet/neutrophil co-operation during myocardial reperfusion. 65
Prostacyclin inhibits the platelet-dependent effects of platelet-activating factor in the rabbit isolated heart. 65
Septic shock--the unravelling of molecular mechanisms. 63
Thrombopoietin contributes to enhanced platelet activation in patients with unstable angina 63
Potential plasticity of T regulatory cells in pancreatic carcinoma in relation to disease progression and outcome 62
Role of platelet-activating factor in cardiovascular pathophysiology. 61
Platelet-activating factor and angiogenesis. 60
Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes. 58
Release of Platelet activating factor (PAF) from ischemic reperfused rabbit heart 57
Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood. 57
In vitro spasmogenic effect of platelet-activating factor on rabbit lung tissue. 57
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 55
Role of platelet-activating factor in acute pancreatitis induced by lipopolysaccharides in rabbits. 54
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 54
Platelet-activating factor contracts human myometrium in vitro. 52
Effects of heparin and its desulfated derivates on leukocyte-endothelial adhesion 51
Platelet activating factor is produced during infectious peritonitis in CAPD patients 51
Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood. 49
Protective effect of Verapamil on the cardiac and circulatory alterations induced by Platelet activating factor 49
Intra-plaque production of platelet-activating factor correlates with neoangiogenesis in human carotid atherosclerotic lesions 48
Role of platelet-activating factor in polymorphonuclear neutrophil recruitment in reperfused ischemic rabbit heart. 48
P.049 Investigation of Novel Circulating Biomarkers in Burn Septic Shock Patients 47
Platelet-activating factor biosynthesis by cultured mesangial cells is modulated by proteinase inhibitors. 47
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 47
Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart 47
Potential angiogenic role of platelet-activating factor in human breast cancer. 46
Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases 46
Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle. 45
Regulation of polymorphonuclear cell activation by thrombopoietin. 45
Role of platelet-activating factor in hypotension andplatelet activation induced by infusion of thrombolytic agents in rabbits. 45
Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. 44
Role of platelet-activating factor (PAF) in oxygen radical-induced cardiac dysfunction. 43
In vitro oxytocic activity of platelet-activating factor on human myometrium. 43
La sepsi e lo shock settico. 43
Plasmin promotes an endothelium-dependent adhesion of neutrophils. Involvement of platelet activating factor andP-selectin. 42
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People 42
Effects of recombinant human megakaryocyte growth and development factor on platelet activation. 42
Role of tumor necrosis factor-alpha and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis. 39
Totale 9.683
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.037
article - articoli 0
book - libri 0
conference - conferenze 799
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.836
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.219 0 0 0 0 0 263 225 122 140 149 182 138
2020/20211.067 96 58 73 38 75 53 130 53 140 127 69 155
2021/20221.465 98 78 77 133 66 93 178 105 72 101 202 262
2022/20231.671 216 119 43 139 137 440 124 105 209 22 82 35
2023/2024654 102 105 49 22 40 105 21 30 2 27 45 106
2024/20251.101 22 161 61 180 539 138 0 0 0 0 0 0
Totale 10.320